News round up 31 July 2017

LSHTM partners LifeArc for tech transfer

London School of Hygiene and Tropical Medicine has signed a deal with LifeArc for the charity to provide a range of technology transfer services to the institution.

Complexa structures $62m series C

Co-led by Pfizer and NEA, the round will support clinical trials of the University of Pittsburgh spinout’s treatments for a kidney disease and a pulmonary condition.

Duolingo dives into series E with $25m

The language learning platform, spun out from Carnegie Mellon University, increased its total funding to $108m with a series E led by Drive Capital that valued it at $700m.

FilterEasy screens $6.9m series B

North Carolina State University’s endowment fund has taken part in a series B round for FilterEasy, which sells air filters for heating, ventilation and air conditioning machines.

Rodeo ropes in corporates for series A

Rodeo Therapeutics has developed therapies to regenerate tissue, based on research undertaken at Case Western Reserve University and University of Texas Southwestern Medical Center.

Signature Medical signs $2.5m deal

Spun out of Boston University by Allied Minds in December last year, Signature Medical has secured $2.5m in series A funding from investors including Bose.

Croda engineers Enza acquisition

Enza Biotech has been purchased by Croda, which hopes to use the Lund University spinout’s technology to enhance its offering of personal care products using sustainable ingredients.

Lentigen breathes in Living Pharma

Living Pharma, an immunotherapy developer, has been acquired just 18 months after being spun out from University of Maryland.

PraxisUnico challenges universities to collaborate

Students once dreamed of headlining Glastonbury, but today’s cohort “want to headline TechCrunch”

Big deal: Samsung emphasises Innoetics acquisition

Innoetics, a text-to-speech developer based on research at Athena, has been acquired by Samsung in the highest value exit of a Greek spinout in decades.